Bristol-Myers Squibb (BMY) earnings

Earnings (net income) · fiscal 2025
$7.05B

Bristol-Myers Squibb (BMY) reported net income of $7.05B in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$8.95B. Figures as of 18 Nov 2026, 04:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$7.05B
Growth, 10 years
+16.2% a year
Highest on record
$10.61Bfiscal 2009
Lowest on record
-$9.02Bfiscal 2020
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bristol-Myers Squibb earnings, in more detail

Over the ten fiscal years to 2025 net income grew at a compound 16.2% a year. Across the 19 fiscal years on record (2007–2025), the highest was $10.61B in fiscal 2009 and the lowest -$9.02B in fiscal 2020.

History · 19 fiscal years

Earnings (net income) by fiscal year

Bristol-Myers Squibb earnings, year by year

Bristol-Myers Squibb (BMY) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$7.05B—
2024-$8.95B 211.5% down
2023$8.03B 26.8% up
2022$6.33B 9.5% down
2021$6.99B—
2020-$9.02B 362.1% down
2019$3.44B 30.1% down
2018$4.92B 388.6% up
2017$1.01B 77.4% down
2016$4.46B 184.8% up
2015$1.57B 21.9% down
2014$2.00B 21.8% down
2013$2.56B 30.8% up
2012$1.96B 47.2% down
2011$3.71B 19.6% up
2010$3.10B 70.8% down
2009$10.61B 102.2% up
2008$5.25B 142.4% up
2007$2.17B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Bristol-Myers Squibb and comparable companies
CompanyEarnings (net income)Fiscal year
Vertex Pharmaceuticals VRTX$3.95B2025
Medtronic MDT$4.80B2026
Bristol-Myers Squibb BMY$7.05B2025
Stryker SYK$3.25B2025
McKesson MCK$4.76B2026
Sanofi SNY€7.81B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BMY

Bristol-Myers Squibb, figure by figure

Bristol-Myers Squibb (BMY) overview: price, valuation and scorecardAll health care companies by market value

Bristol-Myers Squibb earnings: questions and answers

What is Bristol-Myers Squibb's net income?

Bristol-Myers Squibb (BMY) reported net income of $7.05B in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$8.95B.

What is the growth rate of Bristol-Myers Squibb's net income?

Over the ten fiscal years to 2025 net income grew at a compound 16.2% a year.

What are the highest and lowest net income figures on record for Bristol-Myers Squibb?

Across the 19 fiscal years on record (2007–2025), the highest was $10.61B in fiscal 2009 and the lowest -$9.02B in fiscal 2020.

How is Bristol-Myers Squibb's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.